Shares of Novavax Inc. NVAX, -3.61% shed 3.61% to $18.70 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP, -0.25% falling 0.25% to 11,148.64 and Dow Jones Industrial Average DJIA, -0.14% falling 0.14% to 30,273.87. The stock’s fall snapped a two-day winning streak. Novavax Inc. closed $217.80 short of its 52-week high ($236.50), which the company achieved on December 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Replimune Group Inc. REPL, -0.34% fell 0.34% to $17.63, VBI Vaccines Inc. VBIV, -3.98% fell 3.98% to $0.72, and AnaptysBio Inc. ANAB, +1.19% rose 1.19% to $27.29. Trading volume (3.6 M) remained 1.4 million below its 50-day average volume of 5.0 M.